Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$525K Buy
+10,890
New +$508K ﹤0.01% 1532
2025
Q4
Sell
-6,957
Closed -$346K 1893
2025
Q3
$346K Hold
6,957
﹤0.01% 1417
2025
Q2
$343K Sell
6,957
-334,088
-98% -$17.1M ﹤0.01% 1467
2025
Q1
$18.6M Sell
341,045
-289,018
-46% -$15.6M 0.01% 723
2024
Q4
$31M Buy
630,063
+63,195
+11% +$3.21M 0.01% 646
2024
Q3
$31.1M Sell
566,868
-135,190
-19% -$7.3M 0.01% 635
2024
Q2
$34.3M Buy
702,058
+3,820
+0.5% +$184K 0.01% 608
2024
Q1
$31.7M Sell
698,238
-55,325
-7% -$2.7M 0.01% 615
2023
Q4
$39M Buy
753,563
+318,835
+73% +$15.6M 0.02% 584
2023
Q3
$23.7M Buy
+434,728
New +$23.2M 0.01% 665

Other funds holding SNY

Amundi's SNY Position: Q1 2026 in Review

Amundi opened a new position in Sanofi (SNY) in Q1 2026: 10,890 shares worth $525K. The stake represents ﹤0.01% of the portfolio and ranks #1532 among its holdings. This is a return to the name: Amundi previously reported a position in SNY as recently as Q3 2025.

Amundi first reported a position in SNY in Q3 2023 and has held it in 10 quarters since. The position peaked at $39M in Q4 2023. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Amundi held 10,890 shares of Sanofi worth $525K as of Q1 2026.
  • Sanofi was a new Amundi position in Q1 2026.
  • Sanofi made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1532 holding.
  • Amundi first reported a position in Sanofi in Q3 2023 and has held it in 10 quarters since.
  • Amundi's Sanofi position peaked at $39M in Q4 2023.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.